Search company, investor...

Cellular Bioengineering

cellularbioengineering.com

Stage

Convertible Note | Alive

Total Raised

$4.84M

Last Raised

$2M | 9 yrs ago

Revenue

$0000 

About Cellular Bioengineering

Cellular Bioengineering (CBI) is a Hawaii-based accelerator of disruptive technologies with biomedical applications. CBI searches for innovative and ingenious ideas which it can nurture and grow into mature products that will change the way the world operates. Cellular Bioengineering is home to EYEGENIX Artificial Cornea. There are currently 10 million people worldwide with corneal blindness due to the lack of adequate organ donors. CBI has the worldwide license for the development of a bio-integrating polymer corneal substitute which aims to return the gift of sight to these people.

Headquarters Location

650 Iwilei Road Suite 290

Honolulu, Hawaii, 96817,

United States

808-949-2208

Missing: Cellular Bioengineering's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cellular Bioengineering's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cellular Bioengineering Patents

Cellular Bioengineering has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/28/2007

10/4/2016

Dosage forms, Drug delivery devices, Chelating agents, Muscarinic antagonists, Polymers

Grant

Application Date

2/28/2007

Grant Date

10/4/2016

Title

Related Topics

Dosage forms, Drug delivery devices, Chelating agents, Muscarinic antagonists, Polymers

Status

Grant

Cellular Bioengineering Frequently Asked Questions (FAQ)

  • Where is Cellular Bioengineering's headquarters?

    Cellular Bioengineering's headquarters is located at 650 Iwilei Road, Honolulu.

  • What is Cellular Bioengineering's latest funding round?

    Cellular Bioengineering's latest funding round is Convertible Note.

  • How much did Cellular Bioengineering raise?

    Cellular Bioengineering raised a total of $4.84M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.